Skip to main content

Alberto Roque Pérez

Institutions of which they are part

Molecular Medical Imaging
Vall Hebron Institut de Recerca

Alberto Roque Pérez

Institutions of which they are part

Molecular Medical Imaging
Vall Hebron Institut de Recerca

Projects

ARTEMIs: AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients

IP: José Raul Herance Camacho
Collaborators: Beatriz Minguez Rosique, Clara Ramírez Serra, Cristina Gamez Cenzano, Juan Manuel Pericàs Pulido, Nuria Roson Gradaille, Andreea Ciudin Mihai, Alberto Roque Pérez, Queralt Martin Saladich, Maria Nazarena Pizzi
Funding agency: EUROPEAN COMMISSION
Funding: 724000
Reference: ARTEMIS_HE-HLTH2023
Duration: 01/01/2024 - 31/12/2027

SGR

IP: José Raul Herance Camacho
Collaborators: Jorge Guillermo Romero Farina, Cristina Gamez Cenzano, Amparo García Burillo, Sergio Lopez Gandul, Joan Barbeta Sanchez, Manuel Escobar Amores, Ignacio Navales Mateu, SGR, Carina Espinet Coll, Ana Maria Rodriguez Arana, Nuria Roson Gradaille, Eduard Albuixech Ginesta, Mª Carmen López Arribas, Xavier Serres Créixams, Mireia Iniesta Ambrós, Marc Simo Perdigo, Carles Lorenzo Bosquet, Carolina Aparicio Gomez, Alberto Roque Pérez, Queralt Martin Saladich, Gemma Burcet Rodríguez, Lluis Gabalda Martinez, Carmen Sanchez Suarez, Julia Baguña Torres, Esperanza Medina Gutierrez, Hug Cuellar Calabria, Daniel Eiroa Gutierrez, Irati Caballero Bermejo, Maria Teresa Veintemillas Araiz, Alvaro Jesus Valverde Moya, Maria Nazarena Pizzi, Mª Jose Moreno Negrete
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01284
Duration: 01/01/2022 - 30/06/2025

Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs

IP: José Raul Herance Camacho
Collaborators: Fiorella Dellepiane Clarke, Joan Castell Conesa, Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs, Carina Espinet Coll, Nuria Roson Gradaille, Carolina Aparicio Gomez, Alberto Roque Pérez, Mònica Velasco Nuño, Julia Baguña Torres, Irene Hernández Hernández, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI20/01588
Duration: 01/01/2021 - 30/06/2025

Related news

The team will investigate, in animal models, the benefits of histotripsy, a technique that allows tumors to be destroyed without incision or heat, and hopes to minimize the risks and enhance the efficacy of immunotherapy.

This new technology will be completely harmless for patients, as it does not use radiation, and will offer superior image quality and better monitoring of tumours, among other benefits.

The event, organized by Vall d'Hebron and Eurecat, has brought together health professionals and researchers in clinically applied AI to improve the medical care of patients.

Related professionals

Kerrie Adrián Campbell

Kerrie Adrián Campbell

Research technician
Neurovascular Diseases
Read more
Lourdes Elena Salazar Huayna

Lourdes Elena Salazar Huayna

Research technician
Translational Molecular Pathology
Read more
Jordina Beltran Valles

Jordina Beltran Valles

Administration and Management
Clinical Neuroimmunology
Read more
Marina Tarrés Mercader

Marina Tarrés Mercader

Research technician
Gene Therapy at Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.